A detailed history of Putnam Investments LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 44,809 shares of PTCT stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,809
Previous 46,218 3.05%
Holding current value
$1.64 Million
Previous $1.04 Million 19.23%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$18.07 - $29.37 $25,460 - $41,382
-1,409 Reduced 3.05%
44,809 $1.23 Million
Q3 2023

Nov 14, 2023

SELL
$22.41 - $41.99 $8,986 - $16,837
-401 Reduced 0.86%
46,218 $1.04 Million
Q2 2023

Aug 14, 2023

SELL
$40.4 - $59.1 $63,549 - $92,964
-1,573 Reduced 3.26%
46,619 $1.9 Million
Q1 2023

May 22, 2023

SELL
$38.16 - $48.86 $464,597 - $594,870
-12,175 Reduced 20.17%
48,192 $2.33 Million
Q4 2022

Feb 14, 2023

BUY
$33.53 - $54.79 $726,695 - $1.19 Million
21,673 Added 56.01%
60,367 $2.3 Million
Q3 2022

Nov 14, 2022

BUY
$41.85 - $53.85 $1.62 Million - $2.08 Million
38,694 New
38,694 $1.94 Million
Q1 2021

May 17, 2021

SELL
$46.8 - $68.92 $2.99 Million - $4.4 Million
-63,862 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$47.96 - $67.64 $533,075 - $751,818
-11,115 Reduced 14.82%
63,862 $3.9 Million
Q3 2020

Nov 16, 2020

SELL
$45.41 - $57.07 $1.46 Million - $1.83 Million
-32,089 Reduced 29.97%
74,977 $3.51 Million
Q2 2020

Aug 14, 2020

BUY
$42.56 - $54.98 $742,714 - $959,455
17,451 Added 19.47%
107,066 $5.43 Million
Q1 2020

May 15, 2020

BUY
$32.37 - $59.36 $175,348 - $321,553
5,417 Added 6.43%
89,615 $4 Million
Q4 2019

Feb 14, 2020

BUY
$32.22 - $50.07 $2.71 Million - $4.22 Million
84,198 New
84,198 $4.04 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.62B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Putnam Investments LLC Portfolio

Follow Putnam Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Putnam Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Putnam Investments LLC with notifications on news.